Yoshihiro Moriya

Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212)

Shin Fujita, Junki Mizusawa, Yukihide Kanemitsu et al. · Annals of Surgery · 2017 · 436 citations · Full text

Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial

Shin Fujita, Takayuki Akasu, Junki Mizusawa et al. · The Lancet Oncology · 2012 · 358 citations

Surgical Oncology, Mesorectal Excision, Colorectal Surgery +7

Short-Term Surgical Outcomes From a Randomized Controlled Trial to Evaluate Laparoscopic and Open D3 Dissection for Stage II/III Colon Cancer

Seiichiro Yamamoto, Masafumi Inomata, Hiroshi Katayama et al. · Annals of Surgery · 2014 · 346 citations

Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients

Klaas Havenga, Warren E. Enker, Jarle Norstein et al. · European Journal of Surgical Oncology · 1999 · 301 citations

Surgical Oncology, Gastrointestinal Oncology, Colorectal Surgery +8

Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial

Seigo Kitano, Masafumi Inomata, Junki Mizusawa et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 291 citations

Surgical Oncology, Gastrointestinal Oncology, Colorectal Surgery +9